Related Experiment Video
Updated: Jan 17, 2026
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Predicting early recurrence in resectable rectal cancer
Manuel Carmo Silva1, Tiago Correia de Sá2, Kayla P Pereira3
1Department of Radiotherapy, ULS Santa Maria, Lisbon 1649-028, Portugal. mj.oliveiracampos@gmail.com.
Early recurrence (ER) in rectal cancer (RC) can be identified using an 8-month recurrence-free survival cutoff. This finding aids in refining surveillance for high-risk patients, improving survival outcomes.
Area of Science:
- Oncology
- Surgical Oncology
- Clinical Research
Background:
- Early recurrence (ER) is a significant concern in rectal cancer (RC) management.
- Current surveillance strategies may not optimally detect ER, impacting patient survival.
- Neoadjuvant chemoradiotherapy (CRT) reduces locoregional recurrence but may not eliminate ER risk.
More Related Videos
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
08:26Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
Published on: March 24, 2023